Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Regulatory News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
70.00    0.00 (0.00%)
Bid:
69.00
Ask:
71.00
Spread: 2.00 (2.899%)
Market Cap: £318.58m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Directorate Appointment

9 Nov 2007 16:59

Avacta Group plc Board Appointment

Avacta Group plc ("Avacta" or the "Company"), which develops detection and analysis technology aimed at the biopharmaceutical, defence & security and clinical diagnostics markets, is pleased to announce the appointment of Russell Hodgetts to the Board of Directors, with effect from 10 July 2007.

Russell Winston Hodgetts, 36, has been Chief Operating Officer of Avacta since October 2005, and has a wealth of experience in strategic business development and group operations. Prior to joining Avacta he worked for Techtran Group Limited where he helped guide the commercialization and business development of companies created from University of Leeds research and intellectual property.

He currently oversees the development of the analytical services division of the Company in addition to being responsible for group operations.

Russell Hodgetts is the beneficial owner of 9,847,912 ordinary shares of 0.1p each in the capital of the Company ("Ordinary Shares"), representing approximately 1.27 per cent. of the issued share capital of the Company and 1,804,568 options to acquire Ordinary Shares at an exercise price of 2.25p per share.

He is also a director of Avacta Analytical Limited.

Russell Hodgetts was named Russell Beckett until family circumstances led to his name being changed when aged 11.

There are no other disclosures required by paragraph (g) of Schedule 2 of the AIM Rules for Companies.

Professor Alastair Smith, Chief Executive, Avacta Group plc, commented:

"Russell has been an integral part of the development of Avacta over the past two years and his focus on continued growth has been central to the success of Avacta Analytical Ltd. We are pleased to welcome him to the Board and will continue to draw on his knowledge and drive to ensure that Avacta maintains its current path of development and innovation."

9 November 2007EnquiriesAvacta Group plc Tel: 0870 835 4367 Alastair Smith, Chief Executive WH Ireland Limited Tel: 0161 832 2174 David Youngman/Robin Gwyn BankOra Limited Tel: 020 7562 4713 Henry Turcan/Michael Brennan Nexus Financial Ltd Tel: 020 7451 7050 Nicholas Nelson/Kathy Boate nicholas.nelson@nexusgroup.co.uk

AVACTA GROUP PLC
Date   Source Headline
28th Jul 20095:07 pmRNSHolding(s) in Company
13th Jul 20094:40 pmRNSDirector/PDMR Shareholding
10th Jul 20094:17 pmRNSIssue of Equity
9th Jul 20094:29 pmRNSFurther re Acquisition of Theragenetics Limited
23rd Apr 20097:00 amRNSHalf Yearly Report
23rd Apr 20097:00 amPRNOPTIM Product Launch
31st Mar 200912:20 pmPRNAnalyst Presentation
30th Mar 200912:59 pmPRNDirector/PDMR Shareholding
3rd Mar 20091:17 pmRNSCompletion of Acquisition of Curidium Medica plc
2nd Mar 200912:00 pmRNSResult of Court Hearing
12th Feb 20091:23 pmRNSRule 8.1- (Curidium Medica Plc)
11th Feb 20092:09 pmRNSResults of meetings
9th Feb 200912:39 pmRNSResult of EGM
9th Feb 20097:00 amPRNAcquisition
26th Jan 20097:00 amPRNResult of AGM
16th Jan 20097:00 amRNSOffer Update
15th Jan 20099:24 amPRNAcquisition of Theragenetics Limited
9th Jan 200910:12 amRNSAvacta Group plc Acquisition
9th Jan 20097:00 amPRNAcquisition(s)
8th Jan 20092:29 pmRNSDirector/PDMR Shareholding
7th Jan 20097:00 amRNSIssue of Equity
12th Dec 200812:06 pmRNSFinal Results
20th Nov 20084:14 pmRNSDirector/PDMR Shareholding
5th Nov 200812:42 pmRNSIssue of Equity
4th Nov 20087:00 amPRNFinal Results
13th Oct 20087:00 amPRNChange of Adviser
11th Sep 20087:00 amPRNProduct Launch
21st Aug 20087:00 amPRNTrading Statement
14th Aug 200811:03 amPRNProduct Development Partnership
28th Jul 20087:00 amPRNProduct Launch
23rd Jul 20082:54 pmPRNDirector/PDMR Shareholding
14th Apr 20087:00 amPRNHalf-yearly Report
4th Apr 20085:20 pmRNSDirector/PDMR Shareholding
31st Mar 20087:00 amRNSTotal Voting Rights
10th Mar 20083:12 pmRNSIssue of Equity
31st Jan 200811:36 amRNSTotal Voting Rights
7th Jan 200810:50 amPRNRe Agreement
31st Dec 20077:00 amPRNTotal Voting Rights
14th Dec 20073:30 pmPRNAcquisition(s)
14th Dec 20073:05 pmPRNAGM Statement
21st Nov 20077:01 amRNSNotice of AGM
14th Nov 20079:08 amPRNAcquisition
9th Nov 20074:59 pmPRNDirectorate Appointment
25th Sep 20077:00 amPRNFinal Results
3rd Sep 20077:00 amPRNRe Agreement
14th Aug 20073:59 pmRNSAIM Rule 26 Information
13th Aug 20077:00 amPRNRe Agreement
31st Jul 20073:37 pmRNSTotal Voting Rights
26th Jul 20079:53 amPRNIssue of Equity
25th Apr 20074:29 pmPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.